Mitochondrial electron transport chain and mitochondrial membrane lipid pool (ETC/MMLP)

The mitochondrial electron transport chain (ETC) and the associated mitochondrial membrane lipid pool constitute the core machinery for cellular energy production via oxidative phosphorylation. The ETC consists of four multi-subunit protein complexes (I-IV) and two mobile electron carriers, ubiquinone and cytochrome c, which facilitate the transfer of electrons to oxygen while pumping protons across the inner mitochondrial membrane (StatPearls, 2023). The lipid pool, particularly the unique phospholipid cardiolipin, is essential for the structural organization of these complexes into supercomplexes and for maintaining the proton gradient necessary for ATP synthesis (Journal of Lipid Research, 2020). Dysregulation of this system is implicated in a wide range of pathologies, including neurodegenerative disorders like Parkinson's disease, metabolic diseases, and cancer, where metabolic reprogramming often occurs (Nature Reviews Molecular Cell Biology, 2021). Therapeutic strategies targeting this system include ETC inhibitors for oncology, antioxidants to mitigate reactive oxygen species (ROS) damage, and cardiolipin-stabilizing peptides like elamipretide for mitochondrial myopathies (Science Translational Medicine, 2017). However, because this system is fundamental to nearly all eukaryotic cells, targeting it requires high specificity to avoid systemic toxicity and metabolic collapse.

Other names

Oxidative phosphorylation systemOXPHOSMitochondrial respiratory chainMitochondrial lipidomeInner mitochondrial membrane respiratory complexes

Drugs targeting this system typically act by inhibiting specific respiratory complexes (e.g., Complex I or III) to disrupt cancer metabolism, stabilizing mitochondrial lipids like cardiolipin to restore membrane integrity, or acting as electron shuttles to bypass defective chain components.